ArticleGland surgery2026
Peri-areolar dermal reinforcement to prevent prosthetic-related complications in prepectoral reconstruction with a compromised nipple-areola complex: a surgical technique.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In prepectoral direct-to-implant (DTI) breast reconstruction following nipple-sparing mastectomy (NSM) via a hemi-periareolar incision, intraoperative ischemia of the nipple-areola complex (NAC) presents a critical challenge. Existing salvage procedures often require secondary interventions or NAC sacrifice, while leaving a vulnerable suture line resting directly over the implant-acellular dermal matrix (ADM) construct. To address this, we modified a de-epithelialized dermal flap technique, executed directly through the pre-existing incision, to interpose a protective biological barrier beneath the NAC base. This technique was applied in three female patients (aged 43 to 50 years) with breast cancer undergoing unilateral NSM and immediate prepectoral DTI reconstruction with ADM-wrapped implants. Following mastectomy and prior to implant placement, compromised NAC perfusion was recognized by dusky skin discoloration, qualitative indocyanine green angiography demonstrating reduced fluorescence, a capillary refill time of approximately 2 seconds, and preserved dermal edge bleeding. The maneuver was initiated based on the operating surgeon's clinical judgment. A 5- to 10-mm crescent adjacent to the areolar margin was de-epithelialized-leaving a 2- to 3-mm dermal bed-onto which the NAC-bearing flap was advanced and inset. Over follow-up periods ranging from 12 to 48 months, all three patients achieved complete NAC viability without partial or full-thickness necrosis, wound dehiscence, infection, implant exposure, or reoperation. Transient superficial epidermolysis developed on postoperative day 2 but resolved completely by days 14 to 17 with routine local wound care, and nipple position symmetry showed improvement in all cases. This preliminary experience demonstrates that immediate crescent de-epithelialization is technically feasible and yields acceptable clinical outcomes in selected cases. By establishing a dermal safety buffer against implant exposure, this maneuver offers a practical intraoperative salvage strategy. However, three cases from a single center cannot establish overall efficacy or superiority over alternative salvage methods, and larger prospective studies with standardized outcome metrics are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.